Michael S. Cooper, OD
Michael S. Cooper, OD is an Optometrist and Past Director of Professional Strategies at Kala Pharmaceuticals in Arlington, MA. He specializes in anterior segment disease where he has treated a variety of conditions including dry eye and lid diseases, allergy, and uveitis. He has produced research, participated on expert ocular surface disease round tables, and lectured domestically and internationally on topics such as corneal disease states, uveitis management, Lyme disease, emerging pathogens, sports-related eye injuries in children, and AMD pedigree relationships. Dr. Cooper is published in journals such as Review of Optometry, Modern Optometry, Cataract and Refractive Surgery Today, Clinical Ophthalmology, Optometry Times, Primary Care Optometry News, and Ophthalmology/Optometric Management. Additionally, he has collaborated with CollaborativeEYE and Eyetube on a variety of digital media segments including “Managing the Surgical Patient” and “Hot Topics”. He has been actively involved in global clinical studies for novel anti-infective therapeutics, evaluating the efficacy of meibomian gland treatment modalities, ocular surface diagnostic validation, and AMD genetic research. Recently, he was been awarded a federal grant to evaluate Diabetes care efficiency across a multispecialty environment in a community health center setting.
Read the latest articles by Michael S. Cooper, OD
The Optometrist's Guide to Geographic Atrophy
Michael S. Cooper, OD, Daniel Epshtein, OD, FAAO
True Colors: What Dyes Reveal in Ocular Disease with Cheat Sheet
Cindy Hui, OD, Michael S. Cooper, OD
JUST RELEASED: The 2023 Retina Report
Matt Geller, OD, Michael S. Cooper, OD, Eyes On Eyecare Editorial Team